Colorectal cancer in younger patients shows distinct cellular and gene-activity patterns

Key Points:

• Researchers from Mass General Brigham, Dana-Farber Cancer Institute, and the Broad Institute identified biological differences in colorectal tumors that may explain why the cancer behaves more aggressively in younger patients, in a study published in Nature Medicine.
• The study analyzed 189 tumors from patients aged 29 to 90+ using single-nucleus RNA sequencing, revealing that tumors in younger patients have a higher proportion of connective and supporting cells, which are linked to chemotherapy resistance.
• Younger patients' tumors also showed increased activity of long non-coding RNAs and stronger cell signaling associated with cancer cell invasion, suggesting unique cellular patterns compared to older patients.
• While the findings offer new insights into early-onset colorectal cancer, causal relationships remain unproven, and further research is needed to understand immune response differences and potential treatment opportunities.
• The study aims to guide future investigations into prevention, diagnosis, and treatment strategies for younger colorectal cancer patients, addressing the rising incidence and advanced-stage diagnoses in this age group.